BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 24038352)

  • 1. Predicting enhancer transcription and activity from chromatin modifications.
    Zhu Y; Sun L; Chen Z; Whitaker JW; Wang T; Wang W
    Nucleic Acids Res; 2013 Dec; 41(22):10032-43. PubMed ID: 24038352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone H3K4me1 and H3K27ac play roles in nucleosome eviction and eRNA transcription, respectively, at enhancers.
    Kang Y; Kim YW; Kang J; Kim A
    FASEB J; 2021 Aug; 35(8):e21781. PubMed ID: 34309923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-cell profiling reveals that eRNA accumulation at enhancer-promoter loops is not required to sustain transcription.
    Rahman S; Zorca CE; Traboulsi T; Noutahi E; Krause MR; Mader S; Zenklusen D
    Nucleic Acids Res; 2017 Apr; 45(6):3017-3030. PubMed ID: 27932455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA Binding to CBP Stimulates Histone Acetylation and Transcription.
    Bose DA; Donahue G; Reinberg D; Shiekhattar R; Bonasio R; Berger SL
    Cell; 2017 Jan; 168(1-2):135-149.e22. PubMed ID: 28086087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. eRNA binding produces tailored CBP activity profiles to regulate gene expression.
    Bose DA; Berger SL
    RNA Biol; 2017 Dec; 14(12):1655-1659. PubMed ID: 28891741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA transcribed from a distal enhancer is required for activating the chromatin at the promoter of the gonadotropin α-subunit gene.
    Pnueli L; Rudnizky S; Yosefzon Y; Melamed P
    Proc Natl Acad Sci U S A; 2015 Apr; 112(14):4369-74. PubMed ID: 25810254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancer identification in mouse embryonic stem cells using integrative modeling of chromatin and genomic features.
    Chen CY; Morris Q; Mitchell JA
    BMC Genomics; 2012 Apr; 13():152. PubMed ID: 22537144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancer RNA: biogenesis, function, and regulation.
    Ye R; Cao C; Xue Y
    Essays Biochem; 2020 Dec; 64(6):883-894. PubMed ID: 33034351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The degree of enhancer or promoter activity is reflected by the levels and directionality of eRNA transcription.
    Mikhaylichenko O; Bondarenko V; Harnett D; Schor IE; Males M; Viales RR; Furlong EEM
    Genes Dev; 2018 Jan; 32(1):42-57. PubMed ID: 29378788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancer RNAs in cancer: regulation, mechanisms and therapeutic potential.
    Lee JH; Xiong F; Li W
    RNA Biol; 2020 Nov; 17(11):1550-1559. PubMed ID: 31916476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights into Enhancer RNAs: Biogenesis and Emerging Role in Brain Diseases.
    Shen Y; Huang Z; Yang R; Chen Y; Wang Q; Gao L
    Neuroscientist; 2023 Apr; 29(2):166-176. PubMed ID: 34612730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A UTX-MLL4-p300 Transcriptional Regulatory Network Coordinately Shapes Active Enhancer Landscapes for Eliciting Transcription.
    Wang SP; Tang Z; Chen CW; Shimada M; Koche RP; Wang LH; Nakadai T; Chramiec A; Krivtsov AV; Armstrong SA; Roeder RG
    Mol Cell; 2017 Jul; 67(2):308-321.e6. PubMed ID: 28732206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancer transcribed RNAs arise from hypomethylated, Tet-occupied genomic regions.
    Pulakanti K; Pinello L; Stelloh C; Blinka S; Allred J; Milanovich S; Kiblawi S; Peterson J; Wang A; Yuan GC; Rao S
    Epigenetics; 2013 Dec; 8(12):1303-20. PubMed ID: 24135681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HPSE enhancer RNA promotes cancer progression through driving chromatin looping and regulating hnRNPU/p300/EGR1/HPSE axis.
    Jiao W; Chen Y; Song H; Li D; Mei H; Yang F; Fang E; Wang X; Huang K; Zheng L; Tong Q
    Oncogene; 2018 May; 37(20):2728-2745. PubMed ID: 29511351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bidirectional transcription initiation marks accessible chromatin and is not specific to enhancers.
    Young RS; Kumar Y; Bickmore WA; Taylor MS
    Genome Biol; 2017 Dec; 18(1):242. PubMed ID: 29284524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancer transcripts mark active estrogen receptor binding sites.
    Hah N; Murakami S; Nagari A; Danko CG; Kraus WL
    Genome Res; 2013 Aug; 23(8):1210-23. PubMed ID: 23636943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cis-acting lnc-eRNA SEELA directly binds histone H4 to promote histone recognition and leukemia progression.
    Fang K; Huang W; Sun YM; Chen TQ; Zeng ZC; Yang QQ; Pan Q; Han C; Sun LY; Luo XQ; Wang WT; Chen YQ
    Genome Biol; 2020 Nov; 21(1):269. PubMed ID: 33143730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opening up the blackbox: an interpretable deep neural network-based classifier for cell-type specific enhancer predictions.
    Kim SG; Theera-Ampornpunt N; Fang CH; Harwani M; Grama A; Chaterji S
    BMC Syst Biol; 2016 Aug; 10 Suppl 2(Suppl 2):54. PubMed ID: 27490187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancer RNA: What we know and what we can achieve.
    Han Z; Li W
    Cell Prolif; 2022 Apr; 55(4):e13202. PubMed ID: 35170113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancer RNAs step forward: new insights into enhancer function.
    Harrison LJ; Bose D
    Development; 2022 Aug; 149(16):. PubMed ID: 36039999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.